Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$107.53 USD
+0.67 (0.63%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $107.69 +0.16 (0.15%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/18/24 |
---|---|
Current Quarter | 1.10 |
EPS Last Quarter | 0.98 |
Last EPS Surprise | 2.08% |
ABR | 1.53 |
Earnings ESP
|
-0.05% |
---|---|
Current Year | 4.62 |
Next Year | 5.12 |
EPS (TTM) | 4.39 |
P/E (F1) | 23.28 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.35B | 10.55B | 41.66B | 44.53B |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 10.40B | 10.59B | 41.74B | 44.71B |
Low Estimate | 10.29B | 10.51B | 41.60B | 44.33B |
Year ago Sales | 9.98B | 10.14B | 40.11B | 41.66B |
Year over Year Growth Est. | 3.78% | 4.06% | 3.86% | 6.89% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.10 | 1.21 | 4.62 | 5.12 |
# of Estimates | 8 | 6 | 9 | 8 |
Most Recent Consensus | 1.10 | 1.21 | 4.62 | 5.15 |
High Estimate | 1.12 | 1.22 | 4.63 | 5.15 |
Low Estimate | 1.09 | 1.20 | 4.60 | 5.07 |
Year ago EPS | 1.08 | 1.14 | 4.44 | 4.62 |
Year over Year Growth Est. | 1.85% | 6.14% | 4.05% | 10.74% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 5 | 1 |
Up Last 60 Days | 1 | 1 | 5 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 3 | 2 | 3 |
Down Last 60 Days | 2 | 3 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.10 | 1.21 | 4.62 | 5.12 |
7 Days Ago | 1.10 | 1.21 | 4.62 | 5.12 |
30 Days Ago | 1.11 | 1.21 | 4.62 | 5.13 |
60 Days Ago | 1.11 | 1.21 | 4.62 | 5.13 |
90 Days Ago | 1.12 | 1.20 | 4.62 | 5.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.10 | 1.21 | 4.62 | 5.11 |
Zacks Consensus Estimate | 1.10 | 1.21 | 4.62 | 5.12 |
Earnings ESP | -0.05% | 0.07% | 0.12% | -0.03% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.98 | 1.19 | 1.14 | 1.08 | NA |
Estimate | 0.96 | 1.19 | 1.10 | 1.04 | NA |
Difference | 0.02 | 0.00 | 0.04 | 0.04 | 0.03 |
Surprise | 2.08% | 0.00% | 3.64% | 3.85% | 2.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more